PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers report success in treating autism spectrum disorder

2012-07-03
(Press-News.org) CINCINNATI—Using a mouse model of autism, researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have successfully treated an autism spectrum disorder characterized by severe cognitive impairment.

The research team, led by Joe Clark, PhD, a professor of neurology at UC, reports its findings online July 2, 2012, in the Journal of Clinical Investigation, a publication of the American Society for Clinical Investigation.

The disorder, creatine transporter deficiency (CTD) is caused by a mutation in the creatine transporter protein that results in deficient energy metabolism in the brain. Linked to the X chromosome, CTD affects boys most severely; women are carriers and pass it on to their sons.

The brains of boys with CTD do not function normally, resulting in severe speech deficits, developmental delay, seizures and profound mental retardation. CTD is estimated to currently affect about 50,000 boys in the United States and is the second-most common cause of X-linked mental retardation after Fragile X syndrome.

Following CTD's discovery at UC in 2000, researchers at UC and Cincinnati Children's led by Clark discovered a method to treat it with cyclocreatine—also known as CincY, and pronounced cinci-why—a creatine analogue originally developed as an adjunct to cancer treatment. They then treated genetically engineered mice as an animal model of the human disease.

"CincY successfully entered the brain and reversed the mental retardation-like symptoms in the mice, with benefits seen in nine weeks of treatment," says Clark, adding that no harmful effects to the mice were observed in the study. "Treated mice exhibited a profound improvement in cognitive abilities, including recognition of novel objects, spatial learning and memory."

As a repurposed drug (originally developed for another therapy), CincY has already been through part of the U.S. Food and Drug Administration (FDA) approval process. It is taken orally as a pill or powder.

UC's Office of Entrepreneurial Affairs and Technology Commercialization has reached agreement with Lumos Pharma, a privately held Austin, Texas, startup company based on UC technology, to develop and commercialize CincY. Lumos Pharma was created with technology licensed from UC's Office of Entrepreneurial Affairs and Technology Commercialization. Its CEO is Rick Hawkins, a 30-year biotech industry veteran. Jon Saxe is its chairman.

"It has taken many years to get here and I am happy that our efforts have led to this translational effort to make a therapy available to those afflicted with CTD," says Clark. "We look forward with commitment and hope to the day when those patients will benefit from our work."

The collaboration gained momentum when Lumos Pharma submitted a proposal based on Clark's technology to the National Institutes of Health and was selected as a drug development project partner by the National Center for Advancing Translational Sciences' Therapeutics for Rare and Neglected Diseases (TRND) program. Under TRND's collaborative operational model, project partners form joint project teams with TRND and receive in-kind support from TRND drug development scientists, laboratory and contract resources.

Lumos Pharma plans to initiate a TRND-supported preclinical development plan, with TRND support continuing through the filing of an Investigational New Drug (IND) application with the FDA prior to beginning a clinical trial. Such a trial would be about three years away, Clark says.

In addition to Clark, study team members are Yuko Kurosawa, PhD; Ton de Grauw, MD, PhD; Diana Lindquist, PhD; Victor Blanco, PhD; Gail Pyne-Geithman, DPhil; Takiko Daikoku, PhD; James Chambers, PhD; and Stephen Benoit, PhD.

### The research by Clark's team was supported by funding from the National Institutes of Health. The study authors report no conflicts of interest.


ELSE PRESS RELEASES FROM THIS DATE:

BESC researchers tap into genetic reservoir of heat-loving bacteria

2012-07-03
The identification of key proteins in a group of heat-loving bacteria by researchers at the Department of Energy's BioEnergy Science Center could help light a fire under next-generation biofuel production. Scientists have long been on the hunt for cost-effective ways to break down complex plant material such as switchgrass in order to access sugars that are fermented to make biofuels. Conventional processes involve the addition of commercially produced enzymes to break down the cellulose. BESC scientists are exploring alternative options, including the use of certain ...

Mount Sinai finds common factors in autism spectrum disorders, schizophrenia, and bipolar disorder

2012-07-03
A team of researchers have found that schizophrenia or bipolar disorder seen in parents or siblings was associated with increased risk of autism spectrum disorder (ASD). The study was published online by Archives of General Psychiatry on Monday, July 2. Avi Reichenberg, PhD, previously a Visiting Professor and now a new faculty member at the Seaver Autism Center and the Department of Psychiatry at Mount Sinai School of Medicine, and colleagues, used population registers from Sweden and Israel to examine whether a family history of schizophrenia, bipolar disorder, or both, ...

Despite hardships, black men in urban communities are resilient, MU researcher says

2012-07-03
COLUMBIA, Mo. --Black men, especially those living in low-income, urban areas, face many societal stressors, including racial discrimination, incarceration and poverty. In addition, these men have poorer health outcomes. Now, a University of Missouri faculty member has studied these men's efforts to negotiate social environments that are not designed to help them attain good health and success. "Too often, researchers focus on Black men's weaknesses rather than their strengths," said Michelle Teti, assistant professor of health sciences in the MU School of Health Professions. ...

UC Santa Barbara geographer charts the ‘next-generation digital Earth'

2012-07-03
(Santa Barbara, Calif.) –– The world has gotten smaller and more accessible since applications like Google Earth became mainstream, says UC Santa Barbara Professor of Geography Michael Goodchild. However, there is still a long way to go, and there are important steps to take to get there. His perspective, shared with many co-authors around the world, has been published in the Proceedings of the National Academy of Sciences in a paper titled, "Next-generation Digital Earth." Based on former vice-president Al Gore's 1992 vision of a digital replica of Earth, the paper examines ...

Newly discovered dinosaur implies greater prevalence of feathers

2012-07-03
A new species of feathered dinosaur discovered in southern Germany is further changing the perception of how predatory dinosaurs looked. The fossil of Sciurumimus albersdoerferi, which lived about 150 million years ago, provides the first evidence of feathered theropod dinosaurs that are not closely related to birds. The fossil is described in a paper published in the Proceedings of the National Academy of Sciences today. "This is a surprising find from the cradle of feathered dinosaur work, the very formation where the first feathered dinosaur Archaeopteryx was collected ...

Study: Kids with behavior problems, disabilities bullied more, more likely to bully others

2012-07-03
Students receiving special-education services for behavioral disorders and those with more obvious disabilities are more likely to be bullied than their general-education counterparts – and are also more likely to bully other students, a new study shows. The findings, published in the Journal of School Psychology, highlight the complexity of bullying's nature and the challenges in addressing the problem, said lead author Susan Swearer, professor of school psychology at the University of Nebraska-Lincoln. "These results paint a fairly bleak picture for students with ...

DNA sequenced for parrot's ability to parrot

2012-07-03
DURHAM, N.C. -- Scientists say they have assembled more completely the string of genetic letters that could control how well parrots learn to imitate their owners and other sounds. The research team unraveled the specific regions of the parrots' genome using a new technology, single molecule sequencing, and fixing its flaws with data from older DNA-decoding devices. The team also decoded hard-to-sequence genetic material from corn and bacteria as proof of their new sequencing approach. The results of the study appeared online July 1 in the journal Nature Biotechnology. Single ...

Sounding rocket mission to observe magnetic fields on the sun

2012-07-03
On July 5, NASA will launch a mission called the Solar Ultraviolet Magnetograph Investigation or SUMI, to study the intricate, constantly changing magnetic fields on the sun in a hard-to-observe area of the sun's low atmosphere called the chromosphere. Magnetic fields, and the intense magnetic energy they help marshal, lie at the heart of how the sun can create huge explosions of light such as solar flares and eruptions of particles such as coronal mass ejections (CMEs). While there are already instruments – both on the ground and flying in space – that can measure these ...

Researchers create 'rubber-band electronics'

2012-07-03
For people with heart conditions and other ailments that require monitoring, life can be complicated by constant hospital visits and time-consuming tests. But what if much of the testing done at hospitals could be conducted in the patient's home, office, or car? Scientists foresee a time when medical monitoring devices are integrated seamlessly into the human body, able to track a patient's vital signs and transmit them to his doctors. But one major obstacle continues to hinder technologies like these: electronics are too rigid. Researchers at the McCormick School of ...

The advantages of being first

2012-07-03
UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS – How people make choices depends on many factors, but a new study finds people consistently prefer the options that come first: first in line, first college to offer acceptance, first salad on the menu – first is considered best. The paper, "First is Best," recently published in PLoS ONE by Dana R. Carney, assistant professor of management, University of California, Berkeley's Haas School of Business, and co-author Mahzarin R. Banaji, professor of psychology, Harvard University. In three experiments, when ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Researchers report success in treating autism spectrum disorder